Warmly congratulate Shengbai Mixture for being included in the "Expert Consensus on the Diagnosis and Treatment of Bone Marrow Suppression Caused by Antineoplastic Drugs in the Combination of Traditional Chinese and Western Medicine"

2021-09-25

The Expert Consensus on the Diagnosis and Treatment of Bone Marrow Suppression Caused by Antineoplastic Drugs was officially released at the 24th National Congress of Clinical Oncology on September 25, 2021.

Warmly congratulate Mengyang Pharmaceutical Shengbai Oral Liquid (Mixture) for being included in the expert consensus！

PREVFang Hongwei, member of the Standing Committee of the Shaanxi Provincial Party Committee and Secretary-General of the Provincial Party Committee, and his party came to Mengyang, Ningshan for investigation NEXTCongratulations on the successful convening of the RCT research project after the launch of the polysaccharide capsules

Warmly congratulate Shengbai Mixture for being included in the "Expert Consensus on the Diagnosis and Treatment of Bone Marrow Suppression Caused by Antineoplastic Drugs in the Combination of Traditional Chinese and Western Medicine"

Hot news

Mengyang Pharmaceutical's world's ...

The 2023 National Medical Insura...

Brand Leading Inheritance and In...

Gave birth to rise unceasingly, sen...

Our traditional Chinese medicine c...

Mengyang Pharmaceutical Market A...

Mengyang Pharmaceutical announces ...

Expert Consensus Tour of Shengba...

0724-8886111

ABOUT

NEWS

H&R

PRODUCTS

R&D

INVESTOR